HemaSphere (Aug 2023)
P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231
- Margot Roeten,
- Suzanne van Dijk,
- Johan van Meerloo,
- Zinia Kwidama,
- Gaya Jenkins,
- David Teachey,
- Meenakshi Devidas,
- Mignon Loh,
- Gertjan Kaspers,
- Sonja Zweegman,
- Gerrit Jansen,
- Terzah Horton,
- Jacqueline Cloos
Affiliations
- Margot Roeten
- 1 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- Suzanne van Dijk
- 1 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- Johan van Meerloo
- 1 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- Zinia Kwidama
- 1 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- Gaya Jenkins
- 2 Texas Children’s Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, United States
- David Teachey
- 3 Children’s Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania, Department of Pediatrics and the Center for Childhood Cancer Research, Philadelphia, United States
- Meenakshi Devidas
- 4 St Jude Children’s Research Hospital, Department of Global Pediatric Medicine, Memphis, United States
- Mignon Loh
- 5 Seattle Children’s Hospital, Division of Hematology, Oncology, BMT, and Cellular Therapies, Seattle, United States
- Gertjan Kaspers
- 6 Princess Máxima Center of Pediatric Oncology, Utrecht, The Netherlands
- Sonja Zweegman
- 8 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- Gerrit Jansen
- 9 Amsterdam UMC, location Vrije Universiteit, Rheumatology and Immunology Center, Amsterdam, The Netherlands
- Terzah Horton
- 2 Texas Children’s Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, United States
- Jacqueline Cloos
- 1 Amsterdam UMC, location Vrije Universiteit, Department of Hematology, Amsterdam, The Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000968228.81299.a0
- Journal volume & issue
-
Vol. 7
p. e81299a0
Abstract
No abstracts available.